Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Sola Biosciences LLC has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 examiners across 3 art units, indicating examiner dispersion with some art-unit overlap.
STOICA, ELLY GERALD is the busiest examiner, with 1 pending matter. Shared art-unit context may inform portfolio review, but responses should remain tailored to each examiner’s assignment.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STOICA, ELLY GERALD | 1 | 66.8% | +22.6% |
| AEDER, SEAN E | 1 | 57.0% | +20.0% |
| JOHANSEN, PETER N. | 1 | 59.8% | +24.7% |
| LIEB, JEANETTE M | 1 | 79.9% | +17.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17997142 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TDP-43 PROTEINOPATHIES | STOICA, ELLY GERALD | — |
| 18033454 | Compositions and Methods for the Treatment of Alzheimer's Disease | AEDER, SEAN E | — |
| 17995901 | Compositions and Methods for the Treatment of Protein Aggregation Disorders | LIEB, JEANETTE M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18007978 | Compositions and Methods for the Treatment of Synucleinopathies | JOHANSEN, PETER N. | 85d overdue |
| 17997142 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TDP-43 PROTEINOPATHIES | STOICA, ELLY GERALD | — |
| 18033454 | Compositions and Methods for the Treatment of Alzheimer's Disease | AEDER, SEAN E | — |
| 17995901 | Compositions and Methods for the Treatment of Protein Aggregation Disorders | LIEB, JEANETTE M | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1642 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17997142 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TDP-43 PROTEINOPATHIES | STOICA, ELLY GERALD | 1654 | §103§112 | Non-Final OA | — | Pending | May 12, 2023 |
| 18033454 | Compositions and Methods for the Treatment of Alzheimer's Disease | AEDER, SEAN E | 1642 | §103§112 | Non-Final OA | — | Pending | Apr 24, 2023 |
| 18007978 | Compositions and Methods for the Treatment of Synucleinopathies | JOHANSEN, PETER N. | 1644 | §103DP | Final Rejection | 85d overdue | Pending | Dec 02, 2022 |
| 17995901 | Compositions and Methods for the Treatment of Protein Aggregation Disorders | LIEB, JEANETTE M | 1654 | §103§112 | Non-Final OA | — | Pending | Oct 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSola Biosciences LLC has 4 pending office actions as of November 2026, spread across 3 art units and 4 examiners.
Elly Gerald Stoica has the most, with 1 of Sola Biosciences LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.